CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 337 enrolled
Drug / intervention
PresVIEW Scleral Implantsdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01166568
NCT01166568N/ACompleted
CompareCT.gov

A Prospective, Multicenter Clinical Trial Of the PresVIEW Scleral Implant (PSI) For the Improvement Of Near Visual Acuity In Presbyopic Patients

Refocus Group, Inc.·interventional·Posted Jul 21, 2010·Updated Sep 28, 2018

In Brief

A clinical study evaluating PresVIEW Scleral Implants for Presbyopia. Completed, enrolled 337 participants across 14 sites.

Detailed Summary

The primary objective of this study is to evaluate the safety and effectiveness of the PresVIEW™ Scleral Implant (PSI) for the improvement of near visual acuity in presbyopic patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPresbyopia
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 21, 2010
Enrollment StartDec 1, 2003
Primary CompletionMar 1, 2015
TodayJul 2, 2026
Enrollment to primary: 11.3 yearsPosted 15.9 years ago

Interventions

PresVIEW Scleral Implantsdevice

Subjects are implanted with the PresView Scleral Spacing Implants and followed for 24 months.